On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.
More Latest News
December 27, 2018
Please click here for more information regarding extended license expiration deadlines for Registered Pharmacy Technician and Consultant Pharmacist. Continue reading
November 1, 2018
The Annual Report & Long-Range Plan for the 2017-2018 Fiscal Year is now available to view online. Continue reading